Lung epithelial cell-derived C3 protects against pneumonia-induced lung injury
Ayşe Naz Ozantürk(Milliken & Company (United States)), Hrishikesh S. Kulkarni(QB3)
Cited by 2
Related Papers
Clinical review: Serious adverse events associated with the use of rituximab - a critical care perspective
|Critical Care|2012|188
Impaired complement regulation drives chronic lung allograft dysfunction after lung transplantation
|bioRxiv (Cold Spring Harbor Laboratory)|2024|0